Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fundamental aspects of DMPK optimization of targeted protein degraders
Carina Cantrill, Prasoon Chaturvedi, Caroline Rynn, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 6, pp. 969-982
Closed Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan, Matthias G. J. Baud
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 5
Open Access | Times Cited: 239
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective
Andy Pike, Beth Williamson, Stephanie Harlfinger, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 10, pp. 1793-1800
Closed Access | Times Cited: 157
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Shenxin Zeng, Wenhai Huang, Xiaoliang Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112981-112981
Closed Access | Times Cited: 153
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Laura M. Luh, U. Scheib, Katrin Juenemann, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 36, pp. 15448-15466
Open Access | Times Cited: 145
Solution Conformations Shed Light on PROTAC Cell Permeability
Yoseph Atilaw, Vasanthanathan Poongavanam, Caroline Svensson Nilsson, et al.
ACS Medicinal Chemistry Letters (2020) Vol. 12, Iss. 1, pp. 107-114
Open Access | Times Cited: 135
RNA‐PROTACs: Degraders of RNA‐Binding Proteins
Alice Ghidini, Antoine Cléry, François Halloy, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 6, pp. 3163-3169
Open Access | Times Cited: 133
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2576-2607
Closed Access | Times Cited: 131
An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 129
Target and tissue selectivity of PROTAC degraders
Robert G. Guenette, Seung Wook Yang, Jaeki Min, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 14, pp. 5740-5756
Closed Access | Times Cited: 122
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation
Charles E. Hendrick, Jeff R. Jorgensen, Charu Chaudhry, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 7, pp. 1182-1190
Open Access | Times Cited: 88
Degrader-antibody conjugates
Peter S. Dragovich
Chemical Society Reviews (2022) Vol. 51, Iss. 10, pp. 3886-3897
Closed Access | Times Cited: 76
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 69
Linker-Dependent Folding Rationalizes PROTAC Cell Permeability
Vasanthanathan Poongavanam, Yoseph Atilaw, Stephan Siegel, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13029-13040
Open Access | Times Cited: 66
Delivering on the promise of protein degraders
Matthew N. O’Brien, Suman Luthra, Matthew F. Brown, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 410-427
Closed Access | Times Cited: 48
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 47
Advancing Strategies for Proteolysis-Targeting Chimera Design
Minglei Li, Ying Zhi, Bo Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2308-2329
Closed Access | Times Cited: 42
Targeted protein degrader development for cancer: advances, challenges, and opportunities
Yuan Fang, Shuhang Wang, Songzhe Han, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 303-317
Open Access | Times Cited: 38
Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation
Shaowen Xie, Feiyan Zhan, Jingjie Zhu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 13
Open Access | Times Cited: 37
Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates
Murugaiah A. M. Subbaiah, Jarkko Rautio, Nicholas A. Meanwell
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 2099-2210
Closed Access | Times Cited: 18
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 13
Exploring the chemical space of orally bioavailable PROTACs
Giulia Apprato, Vasanthanathan Poongavanam, Diego García Jiménez, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103917-103917
Open Access | Times Cited: 12
Understanding and Improving the Membrane Permeability of VH032-Based PROTACs
Victoria G. Klein, Chad E. Townsend, Andrea Testa, et al.
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 9, pp. 1732-1738
Open Access | Times Cited: 107
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data
Christopher P. Tinworth, Robert J. Young
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 18, pp. 10091-10108
Closed Access | Times Cited: 89
Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity
Victoria G. Klein, Adam G. Bond, Conner Craigon, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 18082-18101
Open Access | Times Cited: 88
Designing Soluble PROTACs: Strategies and Preliminary Guidelines
Diego García Jiménez, Matteo Rossi Sebastiano, Maura Vallaro, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 12639-12649
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top